Volume 8, Issue 2 (May 2021)                   IJML 2021, 8(2): 96-102 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Tabibzadeh A, Naseripour M, Karbalaie Niya M H, Javanmard D, Sadeghipour A, Esghaei M. Molecular Investigation of the Human Adenovirus in Retinoblastoma Patients. IJML. 2021; 8 (2) :96-102
URL: http://ijml.ssu.ac.ir/article-1-382-en.html
Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
Full-Text [PDF 327 kb]   (100 Downloads)     |   Abstract (HTML)  (168 Views)
Full-Text:   (27 Views)
 
Introduction
Retinoblastoma is the most common intraocular malignancy in childhood, critical childhood disease, and rarely diagnosed in young adults [1, 2]. The retinoblastoma prevalence in these age groups involved 4% of all malignancies [1], and their incidence is one per 15000 to 20000 population based on the geographical location [3]. The retinoblastoma 1 gene (RB1) is located in the 13q14chromosome. The RB1 gene is known as a tumor suppressor and regulator of the cell cycle and cell growth. Inactivation in both of the RB1 genes by mutations, deletion, methylation, or single nucleotide alteration leads to tumor development [4-7]. In 1992, the Committee for the Japanese  National Registry of Retinoblastoma reported a five-year survival rate of 93% in unilateral retinoblastoma and a two-year survival rate of 92% for bilateral cases [8]. Also, it was suggested that retinoblastoma could establish due to epigenetic dis-regulation [9]. The higher prevalence of retinoblastoma in low socioeconomic populations suggested a possible association with infection [10-12]. It has been reported that the human papillomavirus (HPV) infection could play a role as causative for the disease [10-14].
Human Adenovirus (HAdV) is a well-known human pathogen, especially for respiratory infections in children [15]. The HAdVs are classified into seven species named A to G and contain more than 70 serotypes [16]. The HAdV types B and D are the causative agents for the epidemic keratoconjunctivitis [17]. The etiologic role of the virus in human malignancies was rigorously studied [18]. The HAdV oncogenesis was firstly introduced by Trentin et al. in 1962 [19]. HAdVs can induce transformation in a wide range of rodents in cell culture [20]. The oncogenesis of the HAdVs in human malignancies did not report. However, there is a focus on the transformation of human cells in vitro [20]. In this regard, HAdV type 5 transformation in the 293 cell line and HAdV 12 transformation in the human embryo retinoblasts were reported previously [21, 22]. Also, the role of the Adenovirus E1B and E1A proteins in human embryo retinoblast transformation was illustrated [23].
Furthermore, epidemiologic investigations could show the virtual prevalence of the viral pathogens so that these studies could be beneficial in the case of retinoblastoma tumorigenesis. The current study aimed to investigate the molecular epidemiology of the HAdV infection in retinoblastoma patients.

Materials and Methods
Participants, demographic and clinical data
In this cross-sectional study, enrolled patient samples were obtained from 96 patients with confirmed retinoblastoma based on the clinical and pathological assessments referred to affiliated hospitals to Iran University of Medical Sciences, Tehran, Iran, from 2015 and 2018. All included patients were primary retinoblastoma cases, and an expert pathologist confirmed the retinoblastoma. The Ethics Committee of Iran University of Medical Sciences (code IR.IUMS.REC.1397.333) approved the study procedure. Written informed consent was obtained from all the included patients. The patients without written informed consent were excluded from the study. The demographic and clinical data were obtained from the laboratory data repository.
Sample preparation and DNA extraction
The pathologically confirmed retinoblastoma formalin-fixed paraffin-embedded (FFPE) tissue blocks were sectioned and prepared for the DNA extraction. Sectioning and extraction were macroscopically performed in the tumor site of the tissue blocks. The DNA extraction was performed by the QIAamp DNA FFPE Tissue Kit (Qiagen, Dusseldorf, Germany) based on the manufacturer's protocols. The NanoDrop ND-1000® spectrophotometry assessed the extraction (Thermo Fisher Scientific Inc., Waltham, MA, USA).
HAdV detection
The human genome in the extracted samples was confirmed using polymerase chain reaction (PCR) for the Human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene. GAPDH was amplified
using 5'-CGACCACTTTGTCAAGCTCA-3' forward
and 5'-AGGGGTCTACATGGCAACTG-3' reverse primers by 228 base pair PCR product in size. The HAdV detection performed by a conventional PCR method using 5'-GCTTCGGAGTACCTGAGYCC-3' forward and 5'-GGCCATRTCCAGCACTCKGT-3' reverse degenerated primers that can amplify a 234 base pair from the HAdV hexone gene. The thermal program for HAdV detection was provided by the Bio-Rad thermal cycler (T100™ Thermal Cycler) and included one step for 5 minutes at 95˚C (pre-denaturation), 40 cycles of 30 seconds at 95˚C (denaturation), 30 seconds at 60˚C (annealing) and 20 seconds at 72˚C (extension) and a final step of 10 minutes at 72˚C (final extension). The same protocol was used for GAPDH, but the annealing was performed at 55˚C for 30 seconds. The PCR products were run in 1% agarose gel after electrophoresis and visualized by ultraviolet light. In all the procedures, careful handling of the samples for minimalizing possible cross-contamination was considered.
Statistical analysis
The statistical evaluation was performed by SPSS version 22 (SPSS Inc., Chicago, IL, USA) using chi-square and Mann–Whitney U test based on the variables. The statistically significant results in the current study considered as p < 0.05.

Results
Patients demographical and pathological features
By assessing 96 included patients, the mean age ± SD of the patients was 28.89 ± 17 months. 49 (53.3%) of patients were male, and 43 (46.7%) were female. The retinoblastoma laterality assessment indicates 87 (90.4%) unilateral and nine (9.4%) bilateral retinoblastomas. The differentiation and growth patterns of tumors are summarized in Table 1. Growth pattern analysis indicates 9 (12%) of tumors with mix endophytic and exophytic patterns. The dominant growth pattern was endophytic 58 (77.3%) and followed by exophytic 8 (10.7%). Tumor involvement of the optic nerve margin was seen in 7 (8.4%) patients. Statistical assessment of the pathological features indicates a statistically significant association between laterality and tumor growth patterns (p = 0.03). In addition, a statistically significant association was seen in optic nerve margin involvement and tumor growth pattern (p = 0.04).
HAdV infection
The retinoblastoma tumor tissue sections were assessed for the HAdV genome using PCR amplification. It was found that there was no HAdV positive sample by the PCR method. Three different concentrations of positive control were used to ensure the primer efficacy for detecting HAdV in RB tumors (Figure 1). The GAPDH gene was used to confirm the presence of the genome in the studied samples. However, all were negative for the virus genome.
 
Table 1. The differentiation, laterality and growth pattern of tumors
Differentiation Pattern Growth Pattern Laterality
Endophytic (%) Exophytic (%) Mix (%) P-value Bilateral (%) Unilateral (%) P-value
Well differentiated 22 (37.9) 2 (25) 1 (12.5) 0.152 1 (16.7) 24 (31.6) 0.182
differentiated 15 (25.9) 1 (12.5) 1 (12.5) 1 (16.7) 19 (25)
Poorly differentiated 1 (1.7) 0 (0) 1 (12.5) 0 (0) 3 (3.9)
Undifferentiated 11 (19) 4 (50) 3 (37.5) 3 (50) 17 (22.4)
Moderate differentiated 3 (5.2) 1 (12.5) 2 (25) 0 (0) 6 (7.9)
Undetermined 6 (10.3) 0 (0) 0 (0) 1 (16.7) 7 (9.2)
 
 

Discussion
The most important etiology of retinoblastoma progression was related to the changes in the RB1 gene as a tumor suppressor. For tumor induction, both alleles of RB1 dysfunction seem to be necessary. In some familial and inherited cases, dysfunction in one allele could be sufficient for tumor induction [24, 25]. As mentioned, the HAdV proteins (E1B and E1A) can transform human embryo retinoblast cell lines [23]. The objective of the current study was to investigate the molecular epidemiology of the HAdV infection in FFPE tissue DNA extracts of retinoblastoma patients by molecular testing. In the present study, 96 patients were included by the mean age ± SD, 28.89 ± 17 months and, 49 (53.3%) of patients were male. The pathological finding for the current study seems to be in accordance with other studies [14, 26]. In the conducted study by Surakiatchanukul et al. [27], the assessment of 82 RB tumors indicates exophytic and endophytic growth patterns in 51 (62%) and 31 (38%) of the patients, respectively. The growth pattern and age were statistically associated with Surakiatchanukul’s study. A statistically significant association between laterality and optic nerve margin involvement with tumor growth pattern was observed in our current study. In addition, growth pattern analysis in our current study indicates nine (12%) tumors with mix endophytic and exophytic patterns, endophytic 58 (77.3%), and exophytic 8 (10.7%). These differences between our study and the conducted study by Surakiatchanukul et al. could be due to the difference in sample size or geographical locations. The conducted study suggested that HAdV 12 can induce transformation in human embryo retinoblasts cells [21]. Gillison et al. [28] suggested that there are no clues about the presence of HAdVs in retinoblastoma by assessing 40 RB tumor samples. Besides, the result of the current study indicates that there was no evidence of the HAdV genome in retinoblastoma samples. The presence of human DNA viruses in RB was suggested by Palazzi and colleagues [29], assessing 43 Brazilian retinoblastoma patients. Palazzi's study indicates the presence of the human papilloma virus (HPV) genome in 27% of the RB tumors. Also, the HAdV in retinoblastoma tumors in the Palazzi was not found. This absence of the HAdV genome in retinoblastoma was either suggested by Ueno et al. [30]. Meanwhile, Javanmard et al. [14] reveal that 9.8% of the assessed retinoblastoma samples show evidence of the HPV genome. The presence of HPV in retinoblastoma samples was reviewed by Chauhan et al. [10]. Furthermore, recent investigations in the field of oncolytic tumors by Pascual-Pasto et al. [31] suggest that the VCN-01 (clinical-grade oncolytic adenovirus) can acts as a therapeutic agent by targeting the RB1 gene in mice model by retinoblastoma xenografts. The major limitations in the current study could include sample size and limitation in the patient's clinical and pathological data, including a date for retinoblastoma diagnosis, records of HAdV infection before cancer diagnosis, tumor type, and tumor staging. Furthermore, the quantitate assessment of virus and the absence of expression level for some important genes in this field could be mentioned as the limitation of this study.

Conclusion
The current study could not show any HAdV genome infection in the assessed retinoblastoma samples. The study results suggest no association between HAdV infection and retinoblastoma tumors in the studied samples. The HAdV infection may not a concern in retinoblastoma pathogenesis. Furthermore, further studies might use full for a clear conclusion about the role of the HAdV or other DNA viruses oncogenesis in retinoblastoma.

Conflict of Interest
There is no conflict of interest.

Acknowledgement
This study was supported by the Iran University of Medical Sciences (grant number: 12332).
 
 
References
[1].   Shields CL, Lally SE. Retinoblastoma, in Ocular Oncology. 2019; Springer, p. 91-99.
[2]. Maat‐Kievit JA, Oepkes D, Hartwig NG, Vermeij‐Keers C, Van Kamp IL, Van De Kamp JJ, A large retinoblastoma detected in a fetus at 21 weeks of gestation. Prenat Diagnos. 1993; 13(5): 377-84.
[3]. Naseripour M, Nazari H, Bakhtiari P, Modarres-zadeh M, Vosough P, Ausari M. Retinoblastoma in Iran: outcomes in terms of patients’ survival and globe survival. Br J Ophthalmol. 2009; 93(1): 28-32.
[4]. Chen PL, Scully P, Shew JY, Wang JY, Lee WH. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 1989; 58(6): 1193-198.
[5]. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, et al. A human
DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323(6089): 643-46.
[6]. Kumaramanickavel G, Joseph B, Narayana K, Natesh S, Mamatha G, Shanmugam MP, et al. Molecular-genetic analysis of two cases
with retinoblastoma: benefits for disease management. J Genet. 2003; 82(1-2): 39-44.
[7]. Lai H, Ma F, Lai S. Identification of the novel role of pRB in eye cancer. J Cel Biochem. 2003; 88(1) :121-27.
[8]. Uemura Y, Matsuda H, Uyama M, Matsuo N, Choshi K. Survival rate and risk factors for patients with retinoblastoma in Japan. Japan J Ophthalmol. 1992; 36(2): 121-31.
[9]. Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Gene Dev. 2009; 23(7): 781-83.
[10]. Chauhan S, Sen S, Singh N, Sharma A, Chawla B, Kashyap S. Human papillomavirus detection strategies in retinoblastoma. Pathol Oncol Res. 2019; 1(1): 1-4.
[11]. Orjuela M, Castaneda VP, Ridaura C, Lecona E, Leal C, Abramson DH, et al. Presence of human papilloma virus in tumor tissue from children with retinoblastoma: an alternative mechanism for tumor development. Clinic Cancer Res. 2000; 6(10): 4010-4016.
[12]. Montoya-Fuentes H, de la Paz Ramirez-Munoz M, Villar-Calvo V, Suarez-Rincon AE, Manuelornelas-Aguirre J, Vazquez-Camacho G, et al. Identification of DNA sequences and viral proteins of 6 human papillomavirus types in retinoblastoma tissue. Anticancer Res. 2003; 23(3C): 2853-862.
[13]. Naru J, Aggarwal R, Singh U, Kakkar N, Bansal D. HPV-16 detected in one-fourth eyes with retinoblastoma: a prospective case-control study from North India. J Pediatric Hematol/Oncol. 2016; 38(5): 367-71.
[14]. Javanmard D, Moein M, Esghaei M, Naseripour M, Monavari SH, Bokharaei‐Salim F, et al. Molecular evidence of human papillomaviruses in the retinoblastoma tumor. Virusdisease 2019; 30(3): 360-66.
[15].Lai CY, Lee CJ, Lu CY, Lee PI, Shao PL, Wu ET, et al. Adenovirus serotype 3 and 7 infection with acute respiratory failure in children in Taiwan, 2010–2011. PloS One 2013; 8(1): 53614.
[16]. Fu Y, Tang Z, Ye Z, Mo S, Tian X, Ni K, et al. Human adenovirus type 7 infection causes a more severe disease than type 3. BMC Infect Dis. 2019; 19(1): 1-10.
[17]. A Aoki K, Kitaichi N, Hinokuma R, Ohno S. Characteristics of epidemic keratoconjunctivitis due to novel adenovirus types. J Clin Ophthalmol Eye Disord. 2017; 1(3): 1013.
[18]. Bogolyubova AV. Human oncogenic viruses: old facts and new hypotheses. Mol Biol. 2019; 53(5): 767-75.
[19]. Trentin JJ, Yabe Y, Taylor G. The quest for human cancer viruses: a new approach to an old problem reveals cancer induction in hamsters by human adenovirus. Science 1962; 137(3533): 835-41.
[20]. Ip WH, Dobner T. Cell transformation by the adenovirus oncogenes E1 and E4. FEBS Letters. 2020; 594(12): 1848-460.
[21]. Byrd P, Brown KW, Gallimore PH. Malignant transformation of human embryo retinoblasts by cloned adenovirus 12 DNA. Nature 1982; 298(5869): 69-71.
[22]. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J General Virol. 1977; 36(1): 59-72.
[23]. Gallimore PH, Grand RJ, Byrd PJ. Transformation of human embryo retinoblasts with simian virus 40, adenovirus and ras oncogenes. Anticancer Res. 1986; 6(3): 499-508.
[24]. Richter S, Vandezande K, Chen N, Zhang K, Sutherland J, Anderson J, et al. Sensitive and efficient detection of RB1 gene mutations enhances care for families with retinoblastoma. Am J Human Genet. 2003; 72(2): 253-69.
[25]. Cavenee WK, Hansen MF, Nordenskjold M, Kock E, Maumenee I, Squire JA, et al. Genetic origin of mutations predisposing to retinoblastoma. Science 1985; 228(4698): 501-503.
[26]. Gao J, Zeng J, Guo B, He W, Chen J, Lu F, et al. Clinical presentation and treatment outcome of retinoblastoma in children of South Western China. Medicine 2016; 95(42): 5204-204.
[27]. Surakiatchanukul WT, Tjoumakaris SI, Jabbour PM, Shields CL. Comparison of primary intra-arterial chemotherapy for retinoblastoma based on exophytic versus Endophytic growth pattern. Investigative Ophthalmology Visual Science 2020; 61(7): 2810-816.
[28]. Gillison ML, Chen R, Goshu E, Rushlow D, Chen N, Banister C, et al. Human retinoblastoma is not caused by known pRb‐inactivating human DNA tumor viruses. Int J Cancer. 2007; 120(7): 1482-490.
[29]. Palazzi MA, Yunes JA, Cardinalli IA, Stangenhaus GP, Brandalise SR, Ferreira SA, et al. Detection of oncogenic human papillomavirus in sporadic retinoblastoma. Acta ophthalmologica Scandinavica 2003; 81(4): 396-98.
[30]. Ueno T, Suzuki N, Kaneko A, Fujinaga K. Analysis of retinoblastoma for human adenovirus and human JC virus genome integration. Japan J ophthalmol. 1987; 31(2): 274-83.
[31]. Pascual-Pasto G, Bazan-Peregrino M, Olaciregui NG, Restrepo-Perdomo CA, Mato-Berciano A, Ottaviani D, et al. Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01. Sci Transl Med. 2019; 11(476): 9321.

 
Type of Study: Research | Subject: Virology
Received: 2020/10/9 | Accepted: 2021/03/14 | Published: 2021/05/31

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2021 CC BY-NC 4.0 | International Journal of Medical Laboratory

Designed & Developed by : Yektaweb